Researchers pinpoint a method to neutralize the Botox toxin.
Researchers made a subtle alteration to the amyloid beta protein. The change affect its aggregation behavior and stabilizes an intermediate form with enhanced toxicity.
A new study reports the interaction between a mitochondrial protein called TOM20 and alpha-synuclein leads to neurodegeneration in Parkinson's disease.
According to researchers, pediatric leukemia patients exposed to high levels of methotrexate are more likely to have problems with mental flexibility and other cognitive skills as long term survivors.
Researchers have identified the point at which proteins in the brain turn toxic during the decent into Parkinson's disease.
Researchers have identified a biomarker that is associated with the activation of an innate immune response to neural damage during the early stages of Alzheimer's disease.
Researchers have uncovered structural markers to differentiate between smaller and larger forms of amyloid beta molecules.
Astrocyte toxicity in ALS may be caused by an explicit loss on MHCI expression in motor neurons, a new study reveals.
A new study reports researchers have identified a drug that targets the first steps in a toxic chain reaction that leads to Alzheimer's disease.
A new study claims researchers have been able to halt the progression of ALS for almost two years in mouse models of the disease.
A new study looks at the toxicity and benefits of the use of anti-prion antibodies.
A new study reports increased neural activity spurs the creation of amyloid beta peptides which are believed to trigger Alzheimer's disease.
